Ping Hou

机构：Tianjin Medical University General Hospital, Hainan Center for Disease Control & Prevention, Tianjin Medical University · ORCID：0000-0003-2783-0728

发表论文 131 篇 · 总被引 4245 次 · h-index 25

代表论文

• Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals (2025 · Journal of Hematology & Oncology · 被引 280)
• Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon-α in lupus nephritis (2018 · Annals of the Rheumatic Diseases · 被引 117)
• Extended Clopidogrel Monotherapy vs DAPT in Patients With Acute Coronary Syndromes at High Ischemic and Bleeding Risk (2024 · JAMA Cardiology · 被引 52)
• Interaction between G ALNT12 and C1GALT1 Associates with Galactose-Deficient IgA1 and IgA Nephropathy (2021 · Journal of the American Society of Nephrology · 被引 40)
• Gastrointestinal mixed adenoneuroendocrine carcinoma: a population level analysis of epidemiological trends (2020 · Journal of Translational Medicine · 被引 27)
• Exome Chip Analyses and Genetic Risk for IgA Nephropathy among Han Chinese (2021 · Clinical Journal of the American Society of Nephrology · 被引 25)